This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
EMEA probes antismoking drug safety
Arimidex “better than tamoxifen”
FDA panel rejects Mevacor request
Access to palliative care “inadequate and inequitable”
EMEA withdraws lumiracoxib from EU
FDA mulls verdict on statin sales
BioMérieux to gradually close site in Netherlands
The role of docetaxel (Taxotere®) in head and neck squamous cell carcinoma (HNSCC) management
MRSA-resistant silver pyjamas to allay hospital fears
Pill given out without prescription
Merck & Co’s cholesterol drugs head promising pipeline
NHS sets price for new painkiller
« Previous
1
…
230
231
232
233
234
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: